7 news Alfred hospital trial of blood cancer drug fir myloid leukemia . trialing a new trug called vaneticlax?? (sounded like that anyway) combined with chemotherapy. Apparently the combined drug triples response rate compared to either drug alone, with few side effects. Seems to have to do with binding to proteins that control leukimia cells and switching on the "death switch" to kill the cancer cell.
Sounds a lot like what we are trying to do, i thought i even recalled something about "death switches" associated with the cpp conjugates?
It would sure be nice to see an anouncement like this with our cpp? I guess we are stull quite away behind and only just trying to start with the mouse model ourselves.
PYC Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)